戻る Agenda
LS28 Discussion with Patients about Rare Disease Drug Development to Improve Drug Lag in Japan
Session Chair(s)
Harumasa Nakamura, MD, PhD
Director of Department of Clinical Research Support, , National Center of Neurology and Psychiatry, Japan
Speaker(s)
Mihoko Kobayashi
Japan Development Leader, Clinical Research, Rare Disease, Pfizer R&D Japan, Japan
Atsushi Nishizawa
Head of Plasma-Derived Therapies Strategy Unit, Takeda Pharmaceutical Company Limited, Japan
Kosuke Ito, PhD
Principal Reviewer, Pharmaceuticals and Medical Devices Agency (PMDA), Japan